MEG3 noncoding RNA: a tumor suppressor
Y Zhou, X Zhang, A Klibanski - Journal of molecular …, 2012 - jme.bioscientifica.com
Maternally expressed gene 3 (MEG3) is an imprinted gene belonging to the imprinted DLK1–
MEG3 locus located at chromosome 14q32. 3 in humans. Its mouse ortholog, Meg3, also …
MEG3 locus located at chromosome 14q32. 3 in humans. Its mouse ortholog, Meg3, also …
[HTML][HTML] Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA
S Ghafouri-Fard, M Taheri - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Abstract Maternally expressed gene 3 (MEG3) is a long non-coding RNA (lncRNA) located
on chromosome 14q32. 3. Direct sequencing experiments have shown monoallelic …
on chromosome 14q32. 3. Direct sequencing experiments have shown monoallelic …
Computational models for lncRNA function prediction and functional similarity calculation
From transcriptional noise to dark matter of biology, the rapidly changing view of long non-
coding RNA (lncRNA) leads to deep understanding of human complex diseases induced by …
coding RNA (lncRNA) leads to deep understanding of human complex diseases induced by …
Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms
V Srirangam Nadhamuni, M Korbonits - Endocrine reviews, 2020 - academic.oup.com
Substantial advances have been made recently in the pathobiology of pituitary tumors.
Similar to many other endocrine tumors, over the last few years we have recognized the role …
Similar to many other endocrine tumors, over the last few years we have recognized the role …
[HTML][HTML] Potential applications of MEG3 in cancer diagnosis and prognosis
Y He, Y Luo, B Liang, L Ye, G Lu, W He - Oncotarget, 2017 - ncbi.nlm.nih.gov
LncRNAs are emerging as integral functional and regulatory components of normal
biological activities and are now considered as critically involved in the development of …
biological activities and are now considered as critically involved in the development of …
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
Y Zhou, X Zhang, A Klibanski - Molecular and cellular endocrinology, 2014 - Elsevier
Human pituitary adenomas are the most common intracranial neoplasms. Approximately 5%
of them are familial adenomas. Patients with familial tumors carry germline mutations in …
of them are familial adenomas. Patients with familial tumors carry germline mutations in …
[HTML][HTML] Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy
IA Qureshi, MF Mehler - Neurotherapeutics, 2013 - Elsevier
The human genome encodes tens of thousands of long non-coding RNAs (lncRNAs), a
novel and important class of genes. Our knowledge of lncRNAs has grown exponentially …
novel and important class of genes. Our knowledge of lncRNAs has grown exponentially …
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies
G Raverot, E Jouanneau… - European journal of …, 2014 - academic.oup.com
Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …
However, various pieces of clinical evidence and recent advances in pathological and …
Genetics of pituitary adenomas
Pituitary adenomas are common tumors of the adenohypophysis which can cause
considerable morbidity, due to excessive hormonal secretion or compression and local …
considerable morbidity, due to excessive hormonal secretion or compression and local …
Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line
P Chunharojrith, Y Nakayama, X Jiang, RE Kery… - Molecular and cellular …, 2015 - Elsevier
Human clinically non-functioning pituitary adenomas (NFAs) account for approximately 40%
of diagnosed pituitary tumors. Epigenetic mutations in tumor suppressive genes play an …
of diagnosed pituitary tumors. Epigenetic mutations in tumor suppressive genes play an …